Mesoblast
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 3 weeks.
- Its last 6 Sell calls were actually followed by a +14% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -30.7% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 2.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 11.18
- Open
- 11.19
- Day range
- 10.87 - 11.44
- Avg price
- 11.09
- Volume
- 192.71K
- Turnover
- 2.14M
- Turnover ratei
- 0.23%
- Volume ratioi
- 0.86
- Amplitudei
- 5.10%
- 52-week rangei
- 10.87 - 21.50
Valuation
- P/Ei
- -24.75
- P/E (TTM)i
- -24.75
- P/Bi
- 2.49
- EPSi
- -0.44
- Book value / shi
- 4.37
- Net profit
- -57.24M
- Net assets
- 568.47M
Share structure
- Market cap
- 1.42B
- Float capi
- 907.01M
- Shares out
- 130.08M
- Float sharesi
- 83.29M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2015-11-13
49.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-1.58M net over the window
Short interest
- Shares short
- 3.58M
- % of floati
- 2.75%
- Days to coveri
- 10.16
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Mesoblast (MESO)?
Mesoblast last traded at 10.89. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Mesoblast's market cap?
About 1.42B.
What is the P/E ratio of Mesoblast?
The trailing twelve-month P/E is -24.75. The Valuation tab shows it against the stock's own five-year range.
Does Mesoblast pay a dividend?
Mesoblast does not currently pay a regular dividend.
Is Mesoblast a buy according to analysts?
The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 37.00, which implies 239.8% upside from the current price. This is not investment advice.
What is Mesoblast's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Mesoblast a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Mesoblast discussion 0 comments